Table 3.
Age-Specific Comparison of Responder Cell Frequency (RCF) Estimates in Healthy Children with Wild-Type Varicella-Zoster Virus (VZV) Infection Versus Human Immunodeficiency Virus (HIV)–Infected Children Who Received Varicella Vaccine
RCF estimate, in responder cells/105 PBMCs |
|||
---|---|---|---|
Age, years | Healthy children with wild-type VZV infection |
HIV-infected children after 2 doses of VZV vaccine |
P |
3 | 3.2 | 1.7 | .07 |
4 | 3.0 | 1.7 | .09 |
5 | 2.7 | 1.7 | .12 |
6 | 2.5 | 1.7 | .15 |
7 | 2.5 | 1.7 | .18 |
8 | 2.3 | 1.7 | .21 |
9 | 2.3 | 1.7 | .22 |
10 | 2.3 | 1.7 | .22 |
NOTE. PBMC, peripheral blood mononuclear cell.